Fenici, Peter

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Thuresson, M., et al. (2017) · Circulation

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 813

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

Heerspink, H. J. L., Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding, J. P. H., Garcia Rodriguez, L. A., Cea-Soriano, L., Kohsaka, S., et al. (2020) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 317

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes ( CVD‐REAL Nordic ) when compared with dipeptidyl peptidase‐4 inhibitor therapy: Amultinational observational study

Persson, F., Nyström, T., Jørgensen, M. E., Carstensen, B., Gulseth, H. L., Thuresson, M., Fenici, P., Nathanson, D., Eriksson, J. W., Norhammar, A., et al. (2018) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 212

Clinical magnetocardiography: the unshielded bet—past, present, and future

Brisinda, D., Fenici, P., & Fenici, R. (2023) · Frontiers in Cardiovascular Medicine

ECG Monitoring and AnalysisAtomic and Subatomic Physics Research

Cited by 80

Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real-world evidence

McEwan, P., Bennett, H., Khunti, K., Wilding, J., Edmonds, C., Thuresson, M., Wittbrodt, E., Fenici, P., & Kosiborod, M. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 58

Magnetocardiographic pacemapping for nonfluoroscopic localization of intracardiac electrophysiology catheters

FENICI, R., PESOLA, K., KORHONEN, P., MÄKIJÄRVI, M., NENONEN, J., TOIVONEN, L., FENICI, P., & KATILA, T. (1998) · Pacing and Clinical Electrophysiology

Cardiac Arrhythmias and TreatmentsECG Monitoring and Analysis

Cited by 22

Clinical Validation of Machine Learning for Automatic Analysis of Multichannel Magnetocardiography

Fenici, R., Brisinda, D., Meloni, A. M., Sternickel, K., & Fenici, P. (2005) · Lecture Notes in Computer Science

ECG Monitoring and AnalysisArtificial Intelligence in Healthcare

Cited by 20

Nonfluoroscopic localization of an amagnetic catheter in a realistic torso phantom by magnetocardiographic and body surface potential mapping

FENICI, R., PESOLA, K., MÄKIJÄRVI, M., NENONEN, J., TEENER, U., FENICI, P., & KATILA, T. (1998) · Pacing and Clinical Electrophysiology

ECG Monitoring and AnalysisCardiac Arrhythmias and Treatments

Cited by 19

First MCG multichannel instrumentation operating in an unshielded hospital laboratory for multi-modal cardiac electrophysiology: preliminary experience

Fenici, R., Brisinda, D., Nenonen, J., Morana, G., & Fenici, P. (2001) · Biomedizinische Technik/Biomedical Engineering

ECG Monitoring and AnalysisCardiac pacing and defibrillation studies

Cited by 8